Candid Health raised $120 million for its AI-driven revenue cycle management platform, supporting expanded deployment of automation in coding, claims, and follow-up workflows. The Series D round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC, and Y Combinator. For biotech and healthcare organizations, tighter RCM performance can influence cash flow and operational capacity, especially as payer complexity and administrative burdens continue to rise. The funding also signals continued investor focus on AI tooling to standardize and accelerate back-office processes in care delivery.